- Nikolaos Perakakis, M.D. IGF-1 LR3
Instructor In Medicine at Harvard Medical School Endocrinologist/Diabetologist - Boston, Massachusetts
Perakakis Nikolaos has a Doctor of Medicine (M.D.) from the Ethnikon kai Kapodistriakon Panepistimion Athinon. Nikolaos Perakakis, M.D. currently works at the Harvard Medical School and has 7 years experience in researching Diabetes and Metabolism at the University of Freiburg. One of their notable works include "Research advances in metabolism 2016". Published online February 2017:41-53. doi:https://doi.org/10.1016/j.metabol.2016.11.001 [PubMed]
Harvard Catalyst Profile | Linkedin | Researchgate - Jagriti Upadhyay M.D. IGF1 LR3
Beth Israel Deaconess Medical Center | BIDMC · Division of Endocrinology, Diabetes and Metabolism - Harvard combined program
Jagriti Upadhyay has a MBBSmedicine from the Christian medical college vellore. Jagriti Upadhyay M.D. currently works at the Beth Israel Deaconess Medical Center and has 3 years experience in researching Diabetes and Metabolism at the Saint Vincent Hospital worcester. One of their notable works include “The role of leptin in regulating bone metabolism. Metabolism”. Published online January 2015:105-113. doi:https://doi.org/10.1016/j.metabol.2014.10.021 [PubMed]
Scholar Google | Researchgate | Linkedin - Frédéric Thuaud PhD Adipotide FTPP
Senior Research Scientist at Sygnature Discovery
Frédéric Thuaud has a Doctor of Philosophy (PhD) from the Université de Strasbourg. Frédéric Thuaud PhD currently works at the ETH Zurich · Laboratory of Organic Chemistry and has 6 years experience in researching Organic Chemistry at the Laboratory of organic chemistry. One of their notable works include “Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential”. Published online 21 March 2013, Pages 316-331. doi:https://doi.org/10.1016/j.chembiol.2013.02.006 [PubMed]
Linkedin | Mendeley | Researchgate - Sam Teichman MD, FACC, FESC, FACP CJC-1295
Global corporate and drug development strategic and operational experience in multiple therapeutic areas including cardiovascular, endocrinology, gastroenterology.
Sam Teichman has a MD, FACC, FESC, FACP from the Columbia University College of Physicians & Surgeons. Sam Teichman MD, FACC, FESC, FACP currently works at the Consultant: Interim CMO and has 9 years experience in researching Multiple therapeutic areas including cardiovascular, endocrinology, gastroenterology at the Columbia University College of Physicians & Surgeons. One of their notable works include Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.. Published online Mar. 2006. doi:http://dx.doi.org/10.1210/jc.2005-1536 [PubMed]
Linkedin | USNews | Mendeley - Hugh McMillan MD, MSc, FRCPC, FAAN ACE-031
Dr. Hugh McMillan is an Associate Professor of Pediatrics at the University of Ottawa, a Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario (CHEO) and a Clinical Investigator at the CHEO Research Institute.
Hugh McMillan has a MD from the McMaster University Medical Centre. Hugh McMillan MD, MSc, FRCPC, FAAN currently works at the Children's Hospital of Eastern Ontario and has 5 years experience in researching ACE-031 Treatment at the CHEO Research Institute. One of their notable works include “Myostatin Inhibitor ACE-031 Treatment of Ambulatory Boys With Duchenne Muscular Dystrophy: Results of a Randomized, Placebo-Controlled Clinical Trial”. Published online February 2017:41-53. doi:http://dx.doi.org/10.1002/mus.25268 [PubMed]
University of Ottawa | Researchgate | CHEO Research Institute - Anita H. Clayton, MD PT-141
Chair of Psychiatry and Neurobehavioral Sciences at the University Of Virginia
Anita Clayton has a M.D. from the University of Virginia. Anita H. Clayton, MD currently works at the University of Virginia and has 30 years experience in researching Psychopharmacology and sexual dysfunction at the University of Virginia. One of their notable works include “Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial”. Published online June 2016. doi:https://doi.org/10.2217/whe-2016-0018 [PubMed]
University of Virginia | Uvahealth | Guilford - Dawn Christianson Ph.D. MD Adipotide FTPP
Over 14 years combined training and experience in the discovery and development of biomarkers into targeted therapeutics.
Dawn Christianson has a Ph.D. from the The University of Texas. Dawn Christianson Ph.D. MD currently works at the Arrowhead Research and has 14 years experience in researching biomarkers into targeted therapeutics at the MD Anderson Cancer Center. One of their notable works include "A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys". Published online 2012 Apr 25. doi:https://dx.doi.org/10.1126/scitranslmed.3002621 [PubMed]
Linkedin | Researchgate | Rocketreach - Graham John Galloway PhD Hexarelin
Chief Executive Officer at National Imaging Facility
Graham John Galloway has a PhD from the Australian National University. Graham John Galloway PhD currently works at the National Imaging Facility and has 3 years experience in researching Cardiac Fibrosis at the Translational Research Institute Australia. One of their notable works include "Hexarelin Treatment Preserves Myocardial Function and Reduces Cardiac Fibrosis in a Mouse Model of Acute Myocardial Infarction”. Published online May 2018. doi:https://doi.org/10.14814/phy2.13699 [PubMed]
Linkedin | Centre UQ | Researchers - Harmanpreet Kaur, PhD TB-500
QA Auditor at Catalent Pharma Solutions
Harmanpreet Kaur has a PhD in Medical Biotechnology from the University of Windsor. Harmanpreet Kaur, PhD currently works at the Catalent Pharma Solutions and has 1 year experience in researching platelet function at the Shaheed Kartar Singh Sarabha College of Nursing. One of their notable works include “Platelet Function and Thymosin Β4.”. Published online July 1, 2012. doi:http://dx.doi.org/10.1515/hsz-2012-0131 [PubMed]
Linkedin | Aminer | Researchgate - Hynda K Kleinman, M.S. PhD Thymosin Beta-4
Science consultant at GtreeBNT
Hynda Kleinman has a PhD from the George Washington University. Hynda K Kleinman, M.S. PhD currently works at the G-TreeBNT and has 3 years experience in researching Thymosin Beta 4 at the NIH. One of their notable works include “Thymosin Beta 4 Induces Hair Growth via Stem Cell Migration and Differentiation”. Published online May 10, 2007. doi:https://doi.org/10.1196/annals.1415.009 [PubMed]
Linkedin | Alliedacademies | Researchgate - Kasper Fjellhaugen Hjuler, MD, PhD Melanotan 2
Staff Specialist and Project Manager, National Centre for Autoimmune Diseases, Department of Dermatology, AUH
Kasper Fjellhaugen Hjuler has a Doctor of Medicine and PhD from the Aarhus University. Kasper Fjellhaugen Hjuler, MD, PhD currently works at the LEO Pharma and has 2 years experience in researching melanotan II at the Dept. of Dermatology, Research Lab S. One of their notable works include "Melanoma Associated with the Use of Melanotan-II". Published online December 18, 2013. doi:https://doi.org/10.1159/000356389 [PubMed]
Linkedin | EuropePMC | Researchgate - Maday Fernández Mayola M.S. GHRP-6
Researcher at Center for Genetic Engineering and Biotechnology
Maday Fernández Mayola has a M.S. from the Center for Genetic Engineering and Biotechnology. Maday Fernández Mayola M.S. currently works at the Center for Genetic Engineering and Biotechnology and has 3 years experience in researching development of new therapeutic strategies at the Center for Genetic Engineering and Biotechnology. One of their notable works include “Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds”. Published online April 20, 2016. doi:https://doi.org/10.1155/2016/4361702 [PubMed]
Linkedin | Researchgate | Maday Fernandez Mayola Facebook - Moshe Phillip, MD Ipamorelin
Director, Institute for Endocrinology and Diabetes National Center at Schneider Children's Medical Center
Moshe Phillip has a Doctorate Degree from the Ben-Gurion University of the Negev. Moshe Phillip, MD currently works at the Institute for Endocrinology and Diabetes National and has 1.5 years experience in researching Endocrinology and Diabetes at the TEL Aviv University. One of their notable works include “Growth Hormone (GH) Hypersecretion and GH Receptor Resistance in Streptozotocin Diabetic Mice in Response to a GH Secretagogue”. Published online 2003. doi:https://doi.org/10.1155/edr.2003.73 [PubMed]
Linkedin | Bloomberg | Diabetestechnology - Nyoman D. Kurniawan PhD Hexarelin
Research Fellow and Microimaging Facility Manager at the Centre for Advanced Imaging
Nyoman D. Kurniawan has a PhD from the The University of Queensland. Nyoman D. Kurniawan PhD currently works at the Centre for Advanced Imaging and has 14 years experience in researching neurodegeneration at the University of Oxford. One of their notable works include "Hexarelin Treatment Preserves Myocardial Function and Reduces Cardiac Fibrosis in a Mouse Model of Acute Myocardial Infarction”. Published online May 2018. doi:https://doi.org/10.14814/phy2.13699 [PubMed]
Researchgate | Centre UQ | Researchers - Perry B. Molinoff, B.S. MD PT-141
Emeritus Professor of Pharmacology
Perry B. Molinoff has a Emeritus Professor of Pharmacology from the Harvard University. Perry B. Molinoff, B.S. MD currently works at the CerSci and has 30 years experience in researching structure and function of cell membrane receptors at the CerSci. One of their notable works include "PT-141: A Melanocortin Agonist for the Treatment of Sexual Dysfunction". Published online June 2003. doi:https://doi.org/10.1111/j.1749-6632.2003.tb03167.x [PubMed]
Perelman School of Medicine | HealthSciencessc | Sharecare - Peter Bygballe Johansen Ph.D. Ipamorelin
Peter Bygballe Johansen, Ph.D., Senior Principal Consultant at Slangerup, Capital Region, Denmark
Peter Johansen has a Ph.D. In Pharmacology from the Royal Danish School of Pharmacy. Peter Bygballe Johansen Ph.D. currently works at the Senior Principal Consultant and has 26 years experience in researching growth hormone, lipids, hypertension, and diabetes at the Novo Nordisk. One of their notable works include “Ipamorelin, a New Growth-Hormone-Releasing Peptide, Induces Longitudinal Bone Growth in Rats”. Published online May 1999. doi:https://doi.org/10.1054/ghir.1999.9998 [PubMed]
Linkedin | Mendeley | Researchgate - Dr. Ruskin R. Lines, MD Melanotan 2
Dermatologist in Gilbert, Arizona. He has been in practice for over 20 years
Ruskin R. Lines has a MD from the University of Arizona College of Medicine. Dr. Ruskin R. Lines, MD currently works at the Banner Baywood Medical Center and has 3 years experience in researching dermatology at the University of Arizona College of Medicine. One of their notable works include "Evaluation of Melanotan-II, a Superpotent Cyclic Melanotropic Peptide in a Pilot Phase-I Clinical Study". Published online April 1996. doi:https://doi.org/10.1016/0024-3205(96)00160-9 [PubMed]
Linkedin | BannerHealth | Health USnews - Yssel Mendoza Marí PhD GHRP-6
Researcher at Center for Genetic Engineering and Biotechnology — Department of Pharmaceutics
Yssel Mendoza has a PhD from the University of Havana. Yssel Mendoza Marí PhD currently works at the Center for Genetic Engineering and Biotechnology and has 22 years experience in researching wound healing at the Center for Genetic Engineering and Biotechnology. One of their notable works include “Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds”. Published online April 20, 2016. doi:https://doi.org/10.1155/2016/4361702 [PubMed]
Scholar Google | Researchgate | Linkedin - Kunihiro Tsuchida PhD Follistatin 315
Fujita Health University, Toyoake, Japan · ICMS, Division fo Therapies against Intractable Diseases
Kunihiro Tsuchida has a PhD from the Fujita Health University. Kunihiro Tsuchida PhD currently works at the Fujita Health University and has 3 years experience in researching Proliferation of Hepatocytes at the Fujita Health University. One of their notable works include “Follistatin 315 Accelerates Proliferation of Hepatocytes after Peak DNA Synthesis in Hepatectomized Rat”. Published online April 2003. doi:https://doi.org/10.1016/s0016-5085(03)80607-8 [PubMed]
Orcid | Scholar Google | Researchgate - Teresa Woodruff Ph.D. Follistatin 315
Teresa K. Woodruff is an American medical researcher in human reproduction and oncology, with a focus on ovarian biology, endocrinology, and women's health. She is the Thomas J. Watkins Memorial Professor and Vice Chair for Research and Chief of the Division of Reproductive Science in Medicine in the Department of Obstetrics and Gynecology at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. Dr. Woodruff is also Dean of the Graduate School and Professor in the McCormick School of Engineering at Northwestern University in Evanston, Illinois. She is credited with coining the term oncofertility and founded the Oncofertility Consortium at Northwestern Memorial Hospital. She is also founder and chief of the Division of Fertility Preservation and founder and director of the Women's Health Research Institute at Northwestern University.
Teresa Woodruff has a PhD from the Olivet Nazarene University. Teresa Woodruff Ph.D. currently works at the Northwestern University and has 3 years experience in researching Structural and Biophysical Coupling at the Northwestern University. One of their notable works include "Structural and Biophysical Coupling of Heparin and Activin Binding to Follistatin Isoform Functions". Published online April 3, 2007. doi:https://doi.org/10.1074/jbc.m700737200 [PubMed]
Wikipedia | Northwestern | Scholar Google - Professor Markus Heinrichs PHD Oxytocin
Director at the Laboratory for Biological and Personality Psychology
Markus Heinrichs has a PhD from the University of Trier. Professor Markus Heinrichs PHD currently works at the University of Freiburg and has 3 years experience in researching oxytocin and social behavior at the University of Trier. One of their notable works include "Oxytocin increases trust in humans". Published online June 2005. doi:https://doi.org/10.1038/nature03701 [PubMed]
Institutes Academies | Researchgate | University of Freiburg - Leanne Green Snyder PhD Oxytocin
Clinical research scientist at SFARI
LeeAnne Green Snyder has a PhD from the University of Connecticut. Leanne Green Snyder PhD currently works at the Simons Foundation and has 1 year experience in researching pediatric psychology autism at the Wayne State University/Children's Hospital of Michigan. One of their notable works include "Plasma oxytocin levels in autistic children". Published online February 1998. doi:https://doi.org/10.1016/s0006-3223(97)00439-3 [PubMed]
Sfari.org | Linkedin | Researchgate - Andre Knoop Ph.D. Sermorelin
Andre Knoop is currently a postdoctoral researcher at Center for Preventive Doping Research
Andre Knoop has a PhD Biochemistry from the German Sport University Cologne. Andre Knoop Ph.D. currently works at the Center for Preventive Doping Research and has 2 years experience in researching Identification of Growth Hormone at the German Sport University Cologne. One of their notable works include "Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS ". Published online May 2016. doi:https://doi.org/10.1007/s00216-016-9377-3 [PubMed]
Linkedin | Researchgate | DSHS Koeln - Dr Richard F Walker, BS, MS, PhD Sermorelin
Biographical Info Researcher and Editor-in-Chief of Clinical Interventions in Aging, a source of factual information for practitioners of age-management medicine.
Richard Walker has a PhD from the University Rutgers University. Dr Richard F Walker, BS, MS, PhD currently works at the University of South Florida and has 10 years experience in researching the study of aging at the Institute Dove Press. One of their notable works include "Sermorelin: A Better Approach to Management of Adult-Onset Growth Hormone Insufficiency?". Published online December 2006. doi:https://doi.org/10.2147/ciia.2006.1.4.307 [PubMed]
Sarcotropin | Researchgate | DovePress - Vladimir Khavinson Ph.D. Epitalon
Vladimir Khavinson is a Professor, Treasurer of the European region of the International Association of Gerontology and Geriatrics; Main gerontologist of the Health Committee of the Government of Saint Petersburg, Russia; Director of the Saint Petersburg Institute of Bioregulation and Gerontology; Vice-president of Gerontological Society of the Russian Academy of Sciences; Head of the Chair of Gerontology and Geriatrics of the North-Western State Medical University, St-Petersburg; Colonel of medical service (USSR, Russia), retired.
Vladmir Khavison has a Doctor of Medicine from the Voyenno-Meditsinskaya Akademiya Imeni S. M. Kirova. Vladimir Khavinson Ph.D. currently works at the St. Petersburg Institute of Bioregulation and Gerontology and has 4 years experience in researching Gene Expression and Protein Synthesis at the St. Petersburg Institute of Bioregulation and Gerontology. One of their notable works include "AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism". Published online 30 Jan 2020. doi:https://doi.org/10.3390/molecules25030609 [PubMed]
Website | Wiki | Sciprofiles - Paulina Marta Gajda, M.Sc. CJC-1295 no DAC
Paulina Marta Gajda is a computer system validation specialist at Waters Corporation. Her research focus areas are analytical chemistry (liquid chromatography, mass spectrometry), biopharmaceuticals and virology.
Paulina Marta Gajda has a M.Sc. Pharmaceutical Science from the University of Copenhagen, Denmark. Paulina Marta Gajda, M.Sc. currently works at the Waters Corporation and has 3 years experience in researching Human growth hormone modification at the University of Copenhagen, Denmark. One of their notable works include "Glycine-modified growth hormone secretagogues identified in seized doping material". Published online Feb 2019. doi:https://doi.org/10.1002/dta.2489 [PubMed]
Rocketreach | Researchgate | Linkedin - Dr. Oleg Hublarov MD Triptorelin
Biographical Info Consultant Urological Surgeon at the Capital Clinic Riga with over 30 years’ experience in urology.
Oleg Hublarov has a MD from the Riga Medical School. Dr. Oleg Hublarov MD currently works at the Klinika LUC and has 2 years experience in researching Erectile dysfunction surgical management at the Clinic of Aesthetic Medicine of Medical Doctor Edward Yurshevich. One of their notable works include "Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer". Published online May 17, 2015. doi:https://doi.org/10.1177/1756287215577329 [PubMed]
Pubmed | CapitalClinicRiga | Linkedin - Mark Heffernan PhD, B.Sc. hGH Fragment 176-191
Heffernan is a Nexvet co-founder. Dr. Heffernan has a B.Sc. in Biochemistry and Pharmacology and a Ph.D. in Biochemistry from Monash University.
Mark Heffernan has a PhD from the Monash University. Mark Heffernan PhD, B.Sc. currently works at the ScoutBio and has 7 years experience in researching biochemistry and molecular biology at the Monash University. One of their notable works include "Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism". Published online September 1, 2000. doi:https://doi.org/10.1152/ajpendo.2000.279.3.e501 [PubMed]
Researchgate | Linkedin | Crunchbase - Mario Staresinic PhD. BPC 157
Assoc. Professor, MD, PhD, General and Sport Trauma and Orthopaedic Consultant
Mario Staresinic has a MD medicine from the University of Zagreb. Mario Staresinic PhD. currently works at the University of Zagreb and has 3 years experience in researching Effect of BPC 157 on Muscle at the Department of Pharmacology, School of Medicine, University of Zagreb. One of their notable works include "Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157". Published online 11 Apr 2006. doi:https://doi.org/10.1002/jor.20089 [PubMed]
PubFacts | Researchgate | Linkedin - Andrew V. Schally, Ph.D., MDHC, DScHC Mod GRF (1-29) 2mg
Medical Research Scientist, Nobel Laureate
Andrew V. Schally has a phD from the McGill University. Andrew V. Schally, Ph.D., MDHC, DScHC currently works at the U.S. Department of Veterans Affairs and has 56 years experience in researching hormonal therapies at the U.S. Department of Veterans Affairs. One of their notable works include "Actions and Potential Therapeutic Applications of Growth Hormone–Releasing Hormone Agonists". Published online May 9, 2019. doi:https://doi.org/10.1210/en.2019-00111 [PubMed]
Nobelprize | UmiamiHealth | Linkedin - Blandine Laferrere, MD GHRP-2
Associate Professor of Medicine at CUMC.
Blandine Laferrere has a MD from the Claude Bernard University (Lyon). Blandine Laferrere, MD currently works at the University in the City of New York and has 39 years experience in researching endocrinology at the Columbia University in the City of New York. One of their notable works include "Obese Subjects Respond to the Stimulatory Effect of the Ghrelin Agonist Growth Hormone-Releasing Peptide-2 on Food Intake". Published online June 2006. doi:https://doi.org/10.1038/oby.2006.121 [PubMed]
ColumbiaDoctors | Nynorc Cuimc | Linkedin - Dmitry A.Sibarov Ph.D. Epitalon (Epithalone or Epithalon)
Biologist working in the area of neuroscience in I.M.Sechenov Institute of Physiology and Biochemistry
D. A. Sibarov has a Ph.D. from the St.Petersburg State University. Dmitry A.Sibarov Ph.D. currently works at the Biotechnologies Inc. company, Russia and has 2 years experience in researching Neuron Activity at the Pavlov Institute of Physiology. One of their notable works include "Effects of intranasal administration of epitalon on neuron activity in the rat neocortex". Published online Nov 2007. doi:https://doi.org/10.1007/s11055-007-0095-3 [PubMed]
Website | Researchgate | Scholar Google - Joachim Mester, BS. GHRP 2
Joachim Mester is a German sports scientist and university professor at German Sport University, Cologne
Joachim Mester has a BS Sports Science from the University of Bochum. Joachim Mester, BS. currently works at the German Sports University, Cologne and has 4 years experience in researching Nutritional Supplement at the German Sport University Cologne. One of their notable works include "Microneedle-Mediated Delivery of Copper Peptide Through Skin". Published online 19 Feb 2015. doi:https://doi.org/10.1007/s11095-015-1652-z [PubMed]
Wikipedia | Researchgate | DSHS Koeln - Degree Janaiah Kota, PhD Follistatin-344
Assistant Professor at School of Medicine and Associate Director at Indiana University Vector Production Facility with over 14 years of experience in clinical product development.
Janaiah Kota has a PhD from the Indian Agricultural Research Institute. Degree Janaiah Kota, PhD currently works at the Indiana University School of Medicine and has 3 years experience in researching translational gene therapy for neuromuscular diseases at the Center for Gene Therapy. One of their notable works include "Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates.". Published online November 11, 2009. doi:https://doi.org/10.1126/scitranslmed.3000112 [PubMed]
Scholar Google | Medicine | Linkedin - Joseph Bornstein MD Fragment 176-191
Dr. Joseph Bornstein, MD is a Colorectal Surgery Specialist in Mobile, AL. Dr. Bornstein has more experience with Colorectal Surgery and Transplant Surgery than other specialists in his area. He is affiliated with Providence Hospital. He is accepting new patients. Be sure to call ahead with Dr. Bornstein to book an appointment.
Joseph Bornstein has a MD Medicine from the Tufts University School of Medicine. Joseph Bornstein MD currently works at the Providence Hospital Mobile and has 4 years experience in researching Human Growth Hormone at the Department of Biochemistry, Monash University. One of their notable works include "Hyperglycemic action of synthetic C-terminal fragments of human growth hormone". Published online 1 May 1978. doi:https://doi.org/10.1152/ajpendo.1978.234.5.e521 [PubMed]
HealthGrades | Healthcare Ascension | Linkedin - Koichi Tsunashima PhD. BPC-157
TOKYO UNIVERSITY, SCHOOL OF MEDICINE, ASSISTANT PROFESSOR
Koichi Tsunashima has a PhD from the TOKYO UNIVERSITY, SCHOOL OF MEDICINE. Koichi Tsunashima PhD. currently works at the The University of Tokyo and has 14 years experience in researching Brain Research at the National Center Hospital for Mental. One of their notable works include "The effect of delta sleep-inducing peptide (DSIP) and phosphorylated DSIP (P-DSIP) on the apomorphine-induced hypothermia in rats". Published online Feb 1990. doi:https://doi.org/10.1016/0006-8993(90)90748-Z [PubMed]
GlobalAuthorID | PubFacts | KAKEN Researcher